Cargando…
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
Functional gastrointestinal disorders (FGIDs) and IBDs are two of the most prevalent disorders of the GI tract and consume a significant proportion of healthcare resources. Recent studies have shown that membrane-bound guanylate cyclase-C (GC-C) receptors lining the GI tract may serve as novel thera...
Autores principales: | Waldman, Scott A, Camilleri, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204952/ https://www.ncbi.nlm.nih.gov/pubmed/29563144 http://dx.doi.org/10.1136/gutjnl-2018-316029 |
Ejemplares similares
-
Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022) -
The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia
por: Rappaport, Jeffrey A., et al.
Publicado: (2018) -
Guanylin, Uroguanylin and Guanylate Cyclase-C Are Expressed in the Gastrointestinal Tract of Horses
por: Cappelli, Katia, et al.
Publicado: (2019) -
Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
por: Vanuytsel, Tim, et al.
Publicado: (2023) -
Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersect
por: Camilleri, Michael
Publicado: (2012)